Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for cyclin dependent kinase 2 (gene)
Most Relevant Literature
- An overview of CDK3 in cancer: clinical significance and pharmacological implications.
- miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in est…
- CDK3 is a major target of miR-150 in cell proliferation and anti-cancer effect.
- Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cance…
- Structural basis of CDK3 activation by cyclin E1 and inhibition by dinaciclib.
Most Relevant Clinical Trials
- A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Adva…
- Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
- Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder
- Evaluation of Skin Health and Quality of Life in Patients Receiving Anti-PD1/PDL1/CTLA4 or Cyclin-de…
- A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With …
